News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Orexo AB (ORXOF) Slumps on Affaersvaerlden Zubsolv Risks


10/2/2013 7:56:06 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Orexo AB (ORX) fell the most in more than a year in Stockholm trading after the Affaersvaerlden business magazine said it sees risks for disappointment when the company presents sales data for its Zubsolv medication this month. The shares dropped as much as 8.8 percent to 114 kronor, their steepest intraday decline since Sept. 21 last year. The stock lost 8 percent to 115 kronor as of 11:44 a.m. local time, making it the biggest decliner among the 278 companies on the OMX Stockholm All-Share Index today.

Help employers find you! Check out all the jobs and post your resume.

Read at Bloomberg


comments powered by Disqus
Bloomberg
Orexo AB
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES